MolNFT v1 · #183474 · protein
Re-refinement of MK3-inhibitor complex
7NRB · MAP kinase-activated protein kinase 3: “Re-refinement of MK3-inhibitor complex”. X-ray diffraction, 1 ligand (P4O), 3 pockets (best druggability 0.61). MolNFT v1 #183474 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7NRB
- Type
- protein
- Length
- 273 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- MAP kinase-activated protein kinase 3
- EC
- 2.7.11.1
- UniProt
- Q16644
- Ligands
- P4O
- Pockets
- 3 · best druggability 0.61
Structure
x-ray diffraction · 1 distinct chain · 43% helix, 22% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | MAP kinase-activated protein kinase 3 (EC 2.7.11.1) | protein | 273 | 43% helix, 22% strand | Q16644 |
Ligands and binding sites
- P4O · 2-(2-quinolin-3-ylpyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 164 | 0.61 | 0.83 | 28 | P4O |
| 2 | 76 | 0.38 | 0.78 | 13 | empty |
| 3 | 59 | 0.31 | 0.75 | 15 | empty |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q16644
- Elsewhere: RCSB PDB 7NRB · PDBe 7NRB · UniProt Q16644
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.